Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with Chemoradiation for HIV-Associated Anal Cancer
NCT00324415Phase 2Completed
- Sponsor
- AIDS Malignancy Consortium
- Start
- Sep 2006
- Primary completion
- Apr 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in anal carcinoma, sponsored by AIDS Malignancy Consortium. Started Sep 2006; status: completed.
02
Drugs
KL-140
03
Conditions
anal carcinoma
Beyond the preview
Go deeper on NCT00324415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00324415.